These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 32575583)
1. Kallikrein-Related Peptidase 14 Activates Zymogens of Membrane Type Matrix Metalloproteinases (MT-MMPs)-A CleavEx Based Analysis. Falkowski K; Bielecka E; Thøgersen IB; Bocheńska O; Płaza K; Kalińska M; Sąsiadek L; Magoch M; Pęcak A; Wiśniewska M; Gruba N; Wysocka M; Wojtysiak A; Brzezińska-Bodal M; Sychowska K; Pejkovska A; Rehders M; Butler G; Overall CM; Brix K; Dubin G; Lesner A; Kozik A; Enghild JJ; Potempa J; Kantyka T Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575583 [TBL] [Abstract][Full Text] [Related]
2. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion. Fillmore HL; VanMeter TE; Broaddus WC J Neurooncol; 2001 Jun; 53(2):187-202. PubMed ID: 11716070 [TBL] [Abstract][Full Text] [Related]
3. Interdependence of kallikrein-related peptidases in proteolytic networks. Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517 [TBL] [Abstract][Full Text] [Related]
4. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137 [TBL] [Abstract][Full Text] [Related]
5. Expression and purification of membrane-type MMPs. Nie J; Pei D Methods Mol Biol; 2010; 622():99-110. PubMed ID: 20135278 [TBL] [Abstract][Full Text] [Related]
7. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064 [TBL] [Abstract][Full Text] [Related]
9. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells. Egawa N; Koshikawa N; Tomari T; Nabeshima K; Isobe T; Seiki M J Biol Chem; 2006 Dec; 281(49):37576-85. PubMed ID: 17050542 [TBL] [Abstract][Full Text] [Related]
10. Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases. Yoon H; Blaber SI; Li W; Scarisbrick IA; Blaber M Biol Chem; 2013 Jan; 394(1):137-47. PubMed ID: 23241590 [TBL] [Abstract][Full Text] [Related]
11. Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin. Emami N; Diamandis EP J Biol Chem; 2008 Feb; 283(6):3031-3041. PubMed ID: 18056261 [TBL] [Abstract][Full Text] [Related]
12. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462 [TBL] [Abstract][Full Text] [Related]
13. Heterotrimeric G proteins directly regulate MMP14/membrane type-1 matrix metalloprotease: a novel mechanism for GPCR-EGFR transactivation. Overland AC; Insel PA J Biol Chem; 2015 Apr; 290(16):9941-7. PubMed ID: 25759388 [TBL] [Abstract][Full Text] [Related]
14. Membrane-type matrix metalloproteases as diverse effectors of cancer progression. Turunen SP; Tatti-Bugaeva O; Lehti K Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1974-1988. PubMed ID: 28390905 [TBL] [Abstract][Full Text] [Related]
15. Cell surface activation of progelatinase A (proMMP-2) and cell migration. Nagase H Cell Res; 1998 Sep; 8(3):179-86. PubMed ID: 9791731 [TBL] [Abstract][Full Text] [Related]
16. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005 [TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation. Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236 [TBL] [Abstract][Full Text] [Related]
18. Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases. Reid JC; Matsika A; Davies CM; He Y; Broomfield A; Bennett NC; Magdolen V; Srinivasan B; Clements JA; Hooper JD Am J Cancer Res; 2017; 7(11):2257-2274. PubMed ID: 29218249 [TBL] [Abstract][Full Text] [Related]
19. Major role of human KLK14 in seminal clot liquefaction. Emami N; Deperthes D; Malm J; Diamandis EP J Biol Chem; 2008 Jul; 283(28):19561-9. PubMed ID: 18482984 [TBL] [Abstract][Full Text] [Related]
20. The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer. Kryza T; Bock N; Lovell S; Rockstroh A; Lehman ML; Lesner A; Panchadsaram J; Silva LM; Srinivasan S; Snell CE; Williams ED; Fazli L; Gleave M; Batra J; Nelson C; Tate EW; Harris J; Hooper JD; Clements JA Mol Oncol; 2020 Jan; 14(1):105-128. PubMed ID: 31630475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]